Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry - Concepedia

Concepedia

Publication | Open Access

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

DOI Full Paper Access

154

Citations

16

References

2012

Year

Maria Elisabetta Zannin, Carolina Birolo, V. Gerloni, Elisabetta Miserocchi, Irene Pontikaki, Maria Pia Paroli, Claudia Bracaglia, Alison Shardlow, Fulvio Parentin, Rolando Cimaz,

The Journal of Rheumatology

Abstract

IFX and ADA appear to be effective and safe for treatment of refractory JIA-related uveitis, with a better performance of ADA in the medium-term period.

References

	Year	Citations

Page 1